Nephrotic syndrome after treatment with 5-aminosalicylic acid.
作者信息
Novis B H, Korzets Z, Chen P, Bernheim J
机构信息
Meir General Hospital, Kfar-Saba, Israel.
出版信息
Br Med J (Clin Res Ed). 1988 May 21;296(6634):1442. doi: 10.1136/bmj.296.6634.1442.
Abstract
摘要
相似文献
1
Nephrotic syndrome after treatment with 5-aminosalicylic acid.5-氨基水杨酸治疗后出现的肾病综合征。
Br Med J (Clin Res Ed). 1988 May 21;296(6634):1442. doi: 10.1136/bmj.296.6634.1442.
2
Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.溃疡性结肠炎使用5-氨基水杨酸导致肾病综合征？并发结肠癌和硬化性胆管炎。
J Clin Gastroenterol. 1997 Jan;24(1):37-9. doi: 10.1097/00004836-199701000-00008.
3
Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
Isr J Med Sci. 1987 Nov;23(11):1161-3.
4
Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
Drug Ther Bull. 1992 Jun 22;30(13):50-2.
5
Oral mesalamine for ulcerative colitis.
Med Lett Drugs Ther. 1992 Aug 21;34(877):80-1.
6
Drug management of ulcerative colitis.溃疡性结肠炎的药物治疗
BMJ. 1992 Oct 3;305(6857):832. doi: 10.1136/bmj.305.6857.832.
7
Lung and skin hypersensitivity to 5-aminosalicylic acid.肺部和皮肤对5-氨基水杨酸的超敏反应。
BMJ. 1991 Apr 20;302(6782):970. doi: 10.1136/bmj.302.6782.970-a.
8
Pentasa (Mesalamine).颇得斯安（美沙拉嗪）。
Gastroenterol Nurs. 1993 Dec;16(3):136-7. doi: 10.1097/00001610-199312000-00010.
9
Asacol: mesalazine for ulcerative colitis.
Drug Ther Bull. 1986 May 19;24(10):38-40.
10
[Salazosulfapyridine or 5-aminosalicylic acid].
Ned Tijdschr Geneeskd. 1987 May 30;131(22):931-4.
引用本文的文献
1
Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.炎症性肠病与慢性肾脏病的风险增加相关，且这种相关性随着年龄的增长而降低。
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2262-2268. doi: 10.1016/j.cgh.2019.10.043. Epub 2019 Nov 1.
2
Do gastroenterologists monitor their patients taking 5-amino-salicylates following initiation of treatment.胃肠病学家在患者开始使用5-氨基水杨酸酯类药物治疗后会对其进行监测吗？
Frontline Gastroenterol. 2015 Jan;6(1):27-31. doi: 10.1136/flgastro-2014-100452. Epub 2014 Jun 4.
3
Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review.美沙拉嗪治疗克罗恩病后出现肾病综合征：病例报告及文献综述
Avicenna J Med. 2012 Jan;2(1):9-11. doi: 10.4103/2231-0770.94804.
4
5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.5-氨基水杨酸是炎症性肠病患者结肠癌化学预防的一种有吸引力的候选药物。
World J Gastroenterol. 2005 Jan 21;11(3):309-14. doi: 10.3748/wjg.v11.i3.309.
5
No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.5-氨基水杨酸无剂量依赖性肾小管毒性：一项针对炎症性肠病患者的前瞻性研究。
Int J Colorectal Dis. 2003 Sep;18(5):406-12. doi: 10.1007/s00384-002-0467-7. Epub 2003 Feb 8.
6
Systemic levels of free 5-aminosalicylic acid depend on the nature of the 5-aminosalicyclic acid derivative and not on disease activity or extent in patients with inflammatory bowel disease.游离5-氨基水杨酸的全身水平取决于5-氨基水杨酸衍生物的性质，而非炎症性肠病患者的疾病活动度或病变范围。
Ir J Med Sci. 1999 Oct-Dec;168(4):228-32. doi: 10.1007/BF02944345.
7
What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?溃疡性结肠炎中5-氨基水杨酸（美沙拉嗪）的剂量是多少？
Gut. 1998 Jun;42(6):761-3. doi: 10.1136/gut.42.6.761.
8
Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.接受氨基水杨酸盐治疗的炎症性肠病患者的肾小管功能障碍
Gut. 1997 Jun;40(6):761-6. doi: 10.1136/gut.40.6.761.
9
Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery.美沙拉嗪的物理化学性质及溶出特性评估：与肠道控释给药的相关性
Pharm Res. 1993 Sep;10(9):1285-90. doi: 10.1023/a:1018909527659.
10
Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.正常儿童中缓释5-氨基水杨酸药物及柳氮磺胺吡啶中5-氨基水杨酸的生物利用度。
Dig Dis Sci. 1993 Oct;38(10):1831-6. doi: 10.1007/BF01296106.
本文引用的文献
1
Nephrotic syndrome induced by tolmetin.托美丁诱发的肾病综合征
JAMA. 1981 Oct 2;246(14):1589.
2
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis.在活动性溃疡性结肠炎中，口服制剂中5-氨基水杨酸的结肠释放情况。
Br J Clin Pharmacol. 1983 Aug;16(2):185-7. doi: 10.1111/j.1365-2125.1983.tb04983.x.
3
5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis.灌肠给药后结肠炎患者血清和尿液中的5-氨基水杨酸
J Pharm Pharmacol. 1983 May;35(5):323-4. doi: 10.1111/j.2042-7158.1983.tb02944.x.
Zotero 插件